Read More

Outset Medical Reports Preliminary Q3 2023 Financial Results; Sees Q3 Revenue $30.4M Vs $27.8M YoY; Total Cash, Including Restricted Cash, Cash Equivalents And Short-Term Investments, Was $197M As Of Sept. 30, 2023

Conference Call Scheduled for 4:30 p.m. ETOutset Medical, Inc. (NASDAQ:OM) ("Outset" or the "Company"), today announced preliminary financial results for the third quarter ended Sept. 30, 2023, and provided updated

OM